Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients (Diabetes Metab J 2024;48:253-64).

Subjects

Subjects :

Humans
Treatment Outcome
Male
Female
Middle Aged
Blood Glucose analysis
Glycated Hemoglobin analysis
Sodium-Glucose Transporter 2 Inhibitors therapeutic use
Sodium-Glucose Transporter 2 Inhibitors administration & dosage
Aged
Diabetes Mellitus, Type 2 drug therapy
Diabetes Mellitus, Type 2 complications
Glucosides therapeutic use
Glucosides administration & dosage
Metformin therapeutic use
Metformin administration & dosage
Benzhydryl Compounds therapeutic use
Benzhydryl Compounds administration & dosage
Sitagliptin Phosphate therapeutic use
Sitagliptin Phosphate administration & dosage
Hypoglycemic Agents therapeutic use
Hypoglycemic Agents administration & dosage
Drug Therapy, Combination

Details

Language :

English

ISSN :

2233-6087

Volume :

48

Issue :

5

Database :

MEDLINE

Journal :

Diabetes & metabolism journal

Publication Type :

Academic Journal

Accession number :

39313235

Full Text :

https://doi.org/10.4093/dmj.2024.0485